Does VENETOCLAX Cause Malignant neoplasm progression? 287 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 287 reports of Malignant neoplasm progression have been filed in association with VENETOCLAX (Venclexta). This represents 0.5% of all adverse event reports for VENETOCLAX.
287
Reports of Malignant neoplasm progression with VENETOCLAX
0.5%
of all VENETOCLAX reports
121
Deaths
87
Hospitalizations
How Dangerous Is Malignant neoplasm progression From VENETOCLAX?
Of the 287 reports, 121 (42.2%) resulted in death, 87 (30.3%) required hospitalization, and 18 (6.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VENETOCLAX. However, 287 reports have been filed with the FAERS database.
What Other Side Effects Does VENETOCLAX Cause?
Death (9,412)
Off label use (6,252)
Neutropenia (3,041)
Febrile neutropenia (2,663)
Platelet count decreased (2,367)
Pyrexia (2,351)
Pneumonia (2,300)
Fatigue (2,281)
Diarrhoea (2,082)
White blood cell count decreased (1,913)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which VENETOCLAX Alternatives Have Lower Malignant neoplasm progression Risk?
VENETOCLAX vs VENLAFAXINE
VENETOCLAX vs VENTAVIS
VENETOCLAX vs VENTOLIN
VENETOCLAX vs VENTOLIN HFA
VENETOCLAX vs VERAPAMIL